Collegium Pharmaceutical is a specialty pharmaceutical company developing and commercializing next generation, abuse-deterrent products for patients suffering from chronic pain. The company has developed a novel, patented, abuse-deterrent technology platform, DETERx, which provides extended-release drug delivery. It was formerly known as Collegium Pharmaceuticals and changed its name to Collegium Pharmaceutical in October 2003. Collegium Pharmaceutical was incorporated in 2002 and is headquartered in Canton, Massachusetts.